Your browser doesn't support javascript.
loading
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Manterola, Andrea; Bernal-Chico, Ana; Cipriani, Raffaela; Ruiz, Asier; Pérez-Samartín, Alberto; Moreno-Rodríguez, Marta; Hsu, Ku-Lung; Cravatt, Benjamin F; Brown, J Mark; Rodríguez-Puertas, Rafael; Matute, Carlos; Mato, Susana.
Afiliação
  • Manterola A; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain.
  • Bernal-Chico A; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain.
  • Cipriani R; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain.
  • Ruiz A; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain.
  • Pérez-Samartín A; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain.
  • Moreno-Rodríguez M; Department of Pharmacology, University of the Basque Country UPV/EHU, 48940, Leioa, Spain.
  • Hsu KL; Department of Chemistry, University of Virginia, 22904, Charlottesville, USA.
  • Cravatt BF; Department of Chemical Physiology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 92037, La Jolla, USA.
  • Brown JM; Department of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, 44195, Cleveland, USA.
  • Rodríguez-Puertas R; Department of Pharmacology, University of the Basque Country UPV/EHU, 48940, Leioa, Spain.
  • Matute C; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain. Electronic address: carlos.matut
  • Mato S; Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain; Achucarro Basque Center for Neuroscience, 48940, Leioa, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029, Madrid, Spain. Electronic address: susana.mato@
Neuropharmacology ; 141: 181-191, 2018 10.
Article em En | MEDLINE | ID: mdl-30171986
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Tratos Piramidais / Triazóis / Benzoatos / Encefalomielite Autoimune Experimental / Terapia de Alvo Molecular / Monoacilglicerol Lipases Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Tratos Piramidais / Triazóis / Benzoatos / Encefalomielite Autoimune Experimental / Terapia de Alvo Molecular / Monoacilglicerol Lipases Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article